Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Boehringer Ingelheim
Johnson and Johnson
Medtronic
Cerilliant
Colorcon
Accenture
UBS

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021438

« Back to Dashboard

NDA 021438 describes INNOPRAN XL, which is a drug marketed by Ani Pharms Inc and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the INNOPRAN XL profile page.

The generic ingredient in INNOPRAN XL is propranolol hydrochloride. There are twenty-one drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.
Summary for 021438
Tradename:INNOPRAN XL
Applicant:Ani Pharms Inc
Ingredient:propranolol hydrochloride
Patents:1
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021438
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 021438
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INNOPRAN XL propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021438 NDA Akrimax Pharmaceuticals, LLC 24090-450 N 24090-450-77
INNOPRAN XL propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021438 NDA Akrimax Pharmaceuticals, LLC 24090-450 N 24090-450-85

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength80MG
Approval Date:Mar 12, 2003TE:BXRLD:No
Patent:➤ Try a Free TrialPatent Expiration:Oct 4, 2021Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength120MG
Approval Date:Mar 12, 2003TE:BXRLD:No
Patent:➤ Try a Free TrialPatent Expiration:Oct 4, 2021Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
Deloitte
Federal Trade Commission
Julphar
Cerilliant
Chubb
US Department of Justice
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.